首页> 外文OA文献 >Optimization Studies on Design and Evaluation of Orodispersible Pediatric Formulation of Indomethacin
【2h】

Optimization Studies on Design and Evaluation of Orodispersible Pediatric Formulation of Indomethacin

机译:消炎痛口腔分散儿科处方设计与评价的优化研究。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

In the present study, the aim was to optimize an orodispersible formulation of indomethacin using a combined approach of subliming agent and superdisintegrant. The tablets were made by non-aqueous wet granulation technique with superdisintegrant incorporated both intragranularly and extragranularly. A 23 factorial design was used to investigate the effects amount of subliming agents namely camphor and ammonium bicarbonate and taste masking and soothening hydrophilic agent mannitol as independent variables and disintegration time and crushing strength as dependent responses. The volatilization time of eight hours at 50°C was optimized by conducting solid-state kinetic studies of optimized formulations. Optimized orodispersible tablets were evaluated for wetting time, water absorption ratio, porosity and in vitro and in vivo disintegration tests. Results show that higher levels of camphor and mannitol and a lower level of ammonium bicarbonate is desirable for orodispersion. Scanning electron microscopy (SEM) revealed the porous surface morphology and kinetic digital images substantiated the orodispersible property. Differential Scanning Calorimetry (DSC) studies exhibited physiochemical compatibility between indomethacin and various excipients used in the tablet formulation. Stability studies carried out as per ICH Q1 A guidelines suggested the stable formulations for the tested time period of 6 months. The systematic approach of using subliming and disintegrating agents helped in achieving a stable, optimized orodispersible formulation, which could be industrially viable.
机译:在本研究中,目的是使用升华剂和超崩解剂的组合方法优化消炎痛的口服分散制剂。通过非水湿法制粒技术将片剂与颗粒内和颗粒外掺入超崩解剂制成片剂。 23因子设计用于研究升华剂(樟脑和碳酸氢铵)的影响量以及掩味和舒缓亲水剂甘露醇(作为独立变量)和崩解时间和压碎强度(作为依存响应)的影响。通过对优化配方进行固态动力学研究,优化了50°C下八小时的挥发时间。评价了优化的口腔分散片的润湿时间,吸水率,孔隙率以及体内和体外崩解试验。结果表明,较高的樟脑和甘露醇含量以及较低的碳酸氢铵含量对于口分散是理想的。扫描电子显微镜(SEM)揭示了多孔表面形态和动力学数字图像证实了口分散性。差示扫描量热法(DSC)研究显示消炎痛与片剂中使用的各种赋形剂之间的理化相容性。根据ICH Q1 A准则进行的稳定性研究表明,经测试的6个月时间范围内的制剂稳定。使用升华和崩解剂的系统方法有助于获得稳定,优化的口腔分散制剂,这在工业上是可行的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号